HOPE-B is a clinical trial by uniQure that is investigating how well AMT-061 works to treat people with severe or moderately severe hemophilia B.
Clinical trials are necessary to learn whether new treatment options are safe and effective. Without patients like you, clinical trials would not happen. As a trial participant, you can actively contribute to the development of new therapies for other patients in the future.
There are a lot of things to consider when deciding to enroll in a clinical trial. Keep reading to learn more about what it would be like to participate in this trial. zzz
Click here to see if you might qualifyinitbutton
What will happen during the trial?
There are 5 phases of the HOPE-B trial
To learn more, access HOPE-B here.
When we have talked about this trial with various people with hemophilia B, here were some of the questions they had…
We know you have a lot of questions. We hope we answered most of them here. Something we missed? Let us know. Contact Us
Join us in the development of a new therapy for hemophilia B
uniQure is delivering on the promise of gene therapy – single treatments with potentially curative results. The company is developing several gene therapies for the treatment of patients with liver/metabolic, central nervous system, and other severe genetic diseases.